Eva B. Schadeck

Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV89.6P challenge in rhesus macaques

Siew-Yen Chong, Michael A. Egan, Michele A. Kutzler et al. · Vaccine · 2007 · 94 citations

Comparative Ability, Vaccine Development, Shiv89.6p Challenge +9

Immunogenicity of Attenuated Vesicular Stomatitis Virus Vectors Expressing HIV Type 1 Env and SIV Gag Proteins: Comparison of Intranasal and Intramuscular Vaccination Routes

Michael A. Egan, Siew Yen Chong, Nina F. Rose et al. · AIDS Research and Human Retroviruses · 2004 · 81 citations

High-Level Expression of the Measles Virus Nucleocapsid Protein by Using a Replication-Deficient Adenovirus Vector: Induction of an MHC-1-Restricted CTL Response and Protection in a Murine Model

Anthony R. Fooks, Eva B. Schadeck, Uwe G. Liebert et al. · Virology · 1995 · 77 citations

Viral Replication, Murine Model, Immunology +8

A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques

Eva B. Schadeck, Maninder K. Sidhu, Michael A. Egan et al. · Vaccine · 2005 · 75 citations

Vaccination, Sivgag-plasmid Dna Vaccine, Vaccine Development +7

Priming with Plasmid DNAs Expressing Interleukin-12 and Simian Immunodeficiency Virus Gag Enhances the Immunogenicity and Efficacy of an Experimental AIDS Vaccine Based on Recombinant Vesicular Stomatitis Virus

Michael A. Egan, Siew Yen Chong, Shakuntala Megati et al. · AIDS Research and Human Retroviruses · 2005 · 72 citations

Vaccination, Primary Immunodeficiency, Mucosal Vaccination +13